date,title,source
Oct-17-18,Alexion Pharmaceuticals (ALXN) Q3 Earnings Preview: What to Know Ahead of the Release,Zacks
Oct-19-18,Berkshire Hathaway Stock Looks Cheap by Warren Buffetts Measure,Barrons.com
Oct-22-18,Alexion (ALXN) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-24-18,Edited Transcript of ALXN earnings conference call or presentation 24-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-24-18,Big Cap 20 Biotech Stock Dives On Mixed Third-Quarter Revenue,Investor's Business Daily
Oct-24-18,Alexion Pharmaceuticals Inc (ALXN) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-24-18,Alexion enters RNA gene-silencing field with $637M Dicerna deal,American City Business Journals
Oct-24-18,"[$$] Alexion 3Q Profit Up, Boosts Revenue Guidance",The Wall Street Journal
Oct-24-18,Alexion Pharmaceuticals (ALXN) Tops Q3 Earnings Estimates,Zacks
Oct-24-18,"Alexion stock rises 3% on Q3 beats, upbeat 2018 guidance",MarketWatch
Oct-24-18,Alexion: 3Q Earnings Snapshot,Associated Press
Oct-24-18,Alexion Reports Third Quarter 2018 Results,Business Wire
Oct-24-18,Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases,Business Wire
Oct-25-18,Edited Transcript of ALXN earnings conference call or presentation 24-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
